Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 29, 2008, Pages 10095-10100

  Yang, Zhiru ^a   Bjorkman, Pamela J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cytomegalovirus; Immune evasion; LIR 1; X ray crystallography

Indexed keywords

BINDING PROTEIN; CARBOHYDRATE; LIR1 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UL18 PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; LIGHT CHAIN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANTIGENS, CD; BINDING SITES; CAPSID PROTEINS; CRYSTALLOGRAPHY, X-RAY; CYTOMEGALOVIRUS; GLYCOSYLATION; HLA-A2 ANTIGEN; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RECEPTORS, VIRUS; SEQUENCE HOMOLOGY, AMINO ACID;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 48249093798     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804551105     Document Type: Article

References (46)

1. Britt WJ, Alford CA (1996) Cytomegalovirus. Fields Virology, eds Fields BN, Knipe DM, Howley PM (Lippincott-Raven, Philadelphia), Vol 2, pp 2493-2523.
2. Ploegh HL (1998) Viral strategies of immune evasion. Science 280:248-253.
3. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244.
4. Yokoyama WM, Kim S, French AR (2004) The dynamic life of natural killer cells. Annu Rev Immunol 22:405-429.
5. Moser JM, Byers AM, Lukacher AE (2002) NK cell receptors in antiviral immunity. Curr Opin Immunol 14:509-516.
6. Cerboni C, et al. (2000) Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol 164:4775-4782.
7. Tomasec P, et al. (2005) Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181-188.
8. Arnon TI, et al. (2005) Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6:515-523.
9. Tomasec P, et al. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
10. Wills MR, et al. (2005) Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175:7457-7465.
11. Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272.
12. Browne H, Smith G, Beck S, Minson T (1990) A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 347:770-772.
13. Fahnestock ML, et al. (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583-590.
14. Wagner CS, Ljunggren HG, Achour A (2008) Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol 180:19-24.
15. Cosman D, et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282.
16. Colonna M, et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818.
17. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH (2002) Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20:853-885.
18. Chapman TL, Heikema AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral MHC homolog UL18. Immunity 11:603-613.
19. Shiroishi M, et al. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 100:8856-8861.
20. Chapman TL, Heikema AP, West AP, Jr, Bjorkman PJ (2000) Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13:727-736.
21. Willcox BE, et al. (2002) Crystal structure of LIR-2 (ILT4) at 1.8 A: Differences from LIR-1 (ILT2) in regions implicated in the binding of the human cytomegalovirus class I MHC homolog UL18. BMC Struct Biol 2:6.
22. Willcox BE, Thomas LE, Bjorkman PJ (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral MHC receptor. Nat Immunol 4:913-919.
23. Shiroishi M, et al. (2006) Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 103:16412-16417.
24. Tomiya N, Betenbaugh MJ, Lee YC (2003) Humanization of lepidopteran insect-cell-produced glycoproteins. Acc Chem Res 36:613-620.
25. Wagner CS, et al. (2007) Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1. J Mol Biol 373:695-705.
26. Cerboni C, et al. (2006) Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur J Immunol 36:732-741.
27. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T (2007) Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 204:907-920.
28. Occhino M, et al. (2008) Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor. J Immunol 180:957-968.
29. Jones S, Thornton JM (1996) Principles of protein-protein interaction. Proc Natl Acad Sci USA 93:13-20.
30. Lawrence MC, Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234:946-950.
31. Molinari M (2007) N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 3:313-320.
32. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24, 419-66.
33. Boyington JC, Brooks AG, Sun PD (2001) Structure of killer cell immunoglobulin-like receptors and their recognition of the class IMHC molecules. Immunol Rev 181:66-78.
34. Park B, et al. (2002) The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. J Immunol 168:3464-3469.
35. Gewurz BE, et al. (2001) Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98:6794-6799.
36. Thilo C, et al. (2006) Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: Prominent role of a single arginine residue in human leukocyte antigen-A2. J Biol Chem 281:8950-8957.
37. Gao GF, et al. (1997) Crystal structure of the complex between human CD8 αα and HLA-A2. Nature 387:630-634.
38. Madden DR (1995) The three dimensional structure of peptide-MHC complexes. Ann Rev Immunol 13:587-622.
39. Leong CC, et al. (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187:1681-1687.
40. - NK cells. J Immunol 178:4473-4481.
41. Otwinowski Z, Minor W (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
42. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674.
43. Brünger AT, et al. (1998) Crystallography and NMR system: A new software system for macromolecular structure determination. Acta Crystallogr D 54:905-921.
44. CCP4 (1994) The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D 50:760-763.
45. DeLano WL (2002) The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, California).
46. Bjorkman PJ, Parham P (1990) Structure, function and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 90:253-288.